The drugmaker Pfizer recently announced that early results from the global trials of a new COVID-19 vaccine showed it was 90% effective in protecting people from the coronavirus. The news boosted hopes that we might be turning a corner in the fight against COVID-19. But it’s important to point out this is early data, and the trial will continue into December. Pfizer has already started manufacturing the vaccine for mass distribution. The company is expected to supply up to 50 million vaccine doses worldwide in 2020 and up to 1.3 billion doses in 2021.
Pfizer’s COVID-19 vaccine shows early promise in global trials
Related Post
-
Does a keto diet increase the risk of birth defects for pregnant women?
A new study suggests pregnant women who follow a ketogenic diet could increase their risk…
-
Eating certain foods can shorten your life
Bad news for you lovers of hot dogs and chicken wings: A new study from…
-
The pandemic has caused screen addiction for almost one-third of Americans
Over half of Americans say they spend more time in front of a screen outside…
-
Survey shows parents and children worried about school this year
A new survey of parents and kids conducted by the University of Michigan shows rising…
-
Cycling might lower your risk of early death
If you want to lower your risk of early death, cycling on a regular basis…
-
A daytime nap might make you more productive than longer sleep at night
If you want to get more work done and make more money, you might consider…